Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis
Cheng Zeng, Fan Dong, Ying Xu, Xiaoju Li, Jiani Yuan, Qian Yang, Xuanxuan Zhou, Jianguo Lu, Cun Zhang, Jun Han, Jintao Gu, Yuan Gao, Lijuan Sun, Siwang Wang
Topics & Concepts
DoxorubicinIn vivoTriple-negative breast cancerApoptosisChemistryCancer researchBreast cancerCancerPharmacologyChemotherapyMedicineBiologyInternal medicineBiochemistryBiotechnologyMicroRNA in disease regulationDrug Transport and Resistance MechanismsRNA Interference and Gene Delivery